Oral rivaroxaban mild bleeding can be observed, severe bleeding should stop the drug immediately, and give blood transfusion or surgical treatment if necessary.
1. Treatment of mild bleeding: mild bleeding should know the site of bleeding, if for the skin mucous membrane, gums, nose bleeding, etc., can be temporarily without medication, take the method of local compression for treatment, the treatment effect is poor should be discontinued in time.
2. Treatment of severe bleeding: some patients may have life-threatening bleeding, such as gastrointestinal bleeding, intracranial hemorrhage, etc. Patients with severe bleeding should stop taking the drug immediately and be given hemostatic treatment, such as intravenous recombinant coagulation factor VIIa, and patients with severe blood loss should be given surgical treatment, and some patients with gastrointestinal tract ulcers can be given emergency surgical hemostatic treatment for bleeding caused by peptic ulcers.
The risk of bleeding should be adequately assessed before oral administration of rivaroxaban, and prophylactic treatment should be given if necessary to prevent bleeding.
Rivaroxaban is an anticoagulant drug, the main adverse reaction is bleeding, allergy to drug components, coagulation dysfunction, severe hepatic insufficiency, active bleeding patients are prohibited.
If bleeding and other adverse reactions occur, it is recommended to consult a doctor in time to avoid delaying the condition.